Privia Health Group Inc

Privia Health Group Inc(PRVA)の株式分析

$21.670

+0.020 (+0.09%)終値時点

Loading chart…
高値
21.970
始値
21.480
出来高加重平均価格
21.70
出来高
1.30M
時価総額
2.04B
安値
21.460
売買代金
28.26M
EV/EBITDA(TTM)
-6,438.54

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

www.priviahealth.com

AI分析 of Privia Health Group Inc (PRVA)

買い

Privia Health Group Inc is a good buy right now due to its current price of $20.85, which is significantly below the analyst price target of $35, indicating a potential upside of 68%. Additionally, the company reported a solid 12.4% year-over-year increase in practice collections for Q2 2026, showcasing strong operational performance. However, a risk to consider is the recent EPS surprise of -12.5%, which may affect short-term investor sentiment.

バリュエーション指標

Privia Health Group Inc(PRVA)の現在の予想PERは17.27で、5年平均は59.16です。

予想PER

適正
5年平均 P/E
59.16
現在のP/E
17.27
割高
343.85
割安
-225.53

予想EV/EBITDA

大幅な割安
5年平均 EV/EBITDA
-109.44
現在のEV/EBITDA
-6438.54
割高
992.97
割安
-1211.86

予想PSR

割安
5年平均 P/S
1.61
現在のP/S
1.03
割高
2.11
割安
1.11

Alphio AI による PRVA の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%PRVA

$29.18

シナリオ価格

基

基本

基本 · 50%PRVA

$27.83

シナリオ価格

弱

弱気

弱気 · 25%PRVA

$24.83

シナリオ価格

PRVA を保有するクジラ

R

Riverbridge Partners, LLC

+ を保有PRVA

+4.24%

3か月リターン

D

Durable Capital Partners, LP

+ を保有PRVA

-6.36%

3か月リターン

イベントタイムライン

2026-08-06 (ET)

06:30:00

Company Reports Q2 Revenue of $632.6M

06:30:00

FY26 Consensus at $2.42, Adjusted EBITDA Expected in $145M-$155M Range

2026-05-27 (ET)

09:10:00

Privia Health Signs Agreement with NGBC to Enter New Jersey

2026-05-07 (ET)

06:20:00

Company Reports Q1 Revenue of $603.8M, Exceeds Consensus

2026-02-26 (ET)

06:30:00

Expects Approximately $600M in Cash by Year-End 2026

ニュース

PRVA のよくある質問 — Alphio AI が回答

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

Privia Health Group Inc is a good buy right now due to its current price of $20.85, which is significantly below the analyst price target of $35, indicating a potential upside of 68%. Additionally, the company reported a solid 12.4% year-over-year increase in practice collections for Q2 2026, showcasing strong operational performance. However, a risk to consider is the recent EPS surprise of -12.5%, which may affect short-term investor sentiment.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める